2877 logo

China Shineway Pharmaceutical Group SHSC:2877 Stock Report

Last Price

HK$9.87

Market Cap

HK$7.5b

7D

-4.0%

1Y

n/a

Updated

26 Mar, 2024

Data

Company Financials +

China Shineway Pharmaceutical Group Limited

SHSC:2877 Stock Report

Market Cap: HK$7.5b

2877 Stock Overview

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.

2877 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends4/6

China Shineway Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Shineway Pharmaceutical Group
Historical stock prices
Current Share PriceHK$9.87
52 Week HighHK$10.72
52 Week LowHK$8.76
Beta0.80
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Change84.14%
5 Year Change20.51%
Change since IPO-30.88%

Recent News & Updates

Recent updates

Shareholder Returns

2877HK PharmaceuticalsHK Market
7D-4.0%0.3%0.3%
1Yn/a-11.3%-12.7%

Return vs Industry: Insufficient data to determine how 2877 performed against the Hong Kong Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 2877 performed against the Hong Kong Market.

Price Volatility

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement7.3%
10% most volatile stocks in HK Market14.7%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 2877 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 2877's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20023,533n/ahttps://www.shineway.com

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM formula granules in various therapeutic areas, including respiratory system disease, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, nervous system, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products.

China Shineway Pharmaceutical Group Limited Fundamentals Summary

How do China Shineway Pharmaceutical Group's earnings and revenue compare to its market cap?
2877 fundamental statistics
Market capHK$7.46b
Earnings (TTM)HK$957.05m
Revenue (TTM)HK$4.91b

7.8x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2877 income statement (TTM)
RevenueCN¥4.53b
Cost of RevenueCN¥1.12b
Gross ProfitCN¥3.42b
Other ExpensesCN¥2.53b
EarningsCN¥883.12m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)1.17
Gross Margin75.37%
Net Profit Margin19.48%
Debt/Equity Ratio4.5%

How did 2877 perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

36%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.